Controllers Up Stakes In Fosun Pharma, Hongbaoli

   Date:2012/02/24

Nanjing Hongbaoli Corporation (002165) and Shanghai Fosun Pharmaceutical (Group) (600196) announced share buy backs by major shareholders, reports Shanghai Securities News, citing a company filing.

Jiangsu Baoyuan Investment, the largest shareholder of Hongbaoli, purchased 527,000 shares, or a 0.19 percent stake, at an average price of 11.24 yuan per share as it is optimistic about the future development prospects of the listed company.

Fosun Pharma said Fosun Group purchased 824,000 shares, or a 0.04 percent interest, yesterday. This brings the total shareholding of Fosun Group to 48.1 percent.

Fosun Group plans to up its stake by up to two percent within the next one year.


 

Source:capitalvue.com

2005- www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号